VENUS REMEDIES
Back to Balance Sheet
|
VENUS REMEDIES Last 5 Year Net Current Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹233 Cr | ₹261 Cr | ₹280 Cr | ₹240 Cr | ₹185 Cr |
What is the latest Net Current Assets ratio of VENUS REMEDIES ?
| Year | Net Current Assets |
|---|---|
| Mar2026 | ₹233 Cr |
| Mar2025 | ₹261 Cr |
| Mar2024 | ₹280 Cr |
| Mar2023 | ₹240 Cr |
| Mar2022 | ₹185 Cr |
How is Net Current Assets of VENUS REMEDIES Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹233 Cr | -10.43 | |
| Mar2025 | ₹261 Cr | -6.95 | |
| Mar2024 | ₹280 Cr | 16.58 | |
| Mar2023 | ₹240 Cr | 29.66 | |
| Mar2022 | ₹185 Cr | - | |
Compare Net Current Assets of peers of VENUS REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VENUS REMEDIES | ₹2,216.5 Cr | -3.3% | 4.8% | 251.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹448,316.0 Cr | -1.9% | -3.7% | 18.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹251,737.0 Cr | 2.6% | 11.1% | 56% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹187,594.0 Cr | 0.2% | 1.3% | 38% | Stock Analytics | |
| CIPLA | ₹110,515.0 Cr | -1.5% | -6.4% | -12.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,420.6 Cr | -1% | -5.1% | -8.1% | Stock Analytics | |
VENUS REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VENUS REMEDIES | -3.3% |
4.8% |
251.5% |
| SENSEX | -2.4% |
-4.8% |
-7.2% |
You may also like the below Video Courses